Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced updates on the regulatory and initial deployment activities for its telehealth platform in Venezuela. The company is advancing early-stage deployment, testing, and refinement of the platform, which is accessible through its digital interface at https://latamedai.org. Current efforts focus on evaluating system performance, user workflows, and operational capabilities as part of the initial launch.
The platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics tools. The company is working to enhance platform functionality, improve data integration, and optimize user experience. In parallel, Catalyst Crew is engaging with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The company is actively progressing through the regulatory process, addressing documentation, operational procedures, and compliance standards.
Management anticipates that the permitting process may be completed in the near term, though no assurance can be given on timing or outcome. This phase of deployment, testing, and regulatory alignment represents an important step toward a broader operational rollout across target markets. Dr. Kevin Rodan Levy, CEO, stated: “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.”
The company continues to develop its digital health and AI platform, including telehealth infrastructure and AI-driven healthcare analytics capabilities. For more information, visit https://catalystcrewai.com or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
